News | February 2023

Eight dQ&A® Abstracts Presented at ATTD 2023

We are excited to announce that the dQ&A team presented eight abstracts at the Advanced Technologies and Treatments for Diabetes (ATTD) 2023 conference, spanning many different topics:

  • Reasons for pump adoption hesitancy among people with diabetes in the U.S. taking multiple daily injections (Alison Zeng et al.)
  • Awareness of CGM and barriers to use among people with diabetes in six European countries (Evelyn Cox et al.)
  • In-person versus virtual insulin pump training experiences among people with diabetes in six European countries (Emily Lin et al.)
  • Understanding the impact of neuropathy on treatment administration for people with diabetes (Alison Zeng et al.)
  • Desired improvements to health apps among people with diabetes in Europe (Evelyn Cox et al.)
  • Challenges to exercising among people with diabetes using diabetes technologies in the US, Canada, and Europe (Emily Xu et al.)
  • Awareness of insulin pump therapy and barriers to use vary by demographic group among people with diabetes in Europe (Evelyn Cox et al.)
  • Exploring the impact of mobile apps on self-management and clinical care for people with diabetes in the United States (Trevor Bell et al.)

Send us an email to receive this research and to learn what else our team is working on!

About dQ&A – The Diabetes Research Company

dQ&A is a social enterprise committed to making life better for people with diabetes. We harness patient voices to drive better business results and better health outcomes. For over 14 years, we have been comprehensively tracking the diabetes experience in the United States, Canada, and Europe. We are trusted by diabetes industry leaders for our independence, commitment, and expertise. Our team has decades of experience in quantitative and qualitative research with a deep knowledge of diabetes. We’re efficient and effective; our insights are actionable and accessible. To learn more, send us an email at For research highlights, visit us at and follow us on LinkedIn (dQ&A – The Diabetes Research Company)